CCAAT-Enhancer-Binding Protein-delta
"CCAAT-Enhancer-Binding Protein-delta" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the C-EBP protein family of transcription factors. It plays a key role in G0 PHASE mammary EPITHELIAL CELL growth arrest, and it is involved in transcriptional regulation of INTERLEUKIN 1; INTERLEUKIN 6; and TUMOR NECROSIS FACTOR-ALPHA.
| Descriptor ID |
D051743
|
| MeSH Number(s) |
D12.776.260.108.124.812 D12.776.660.167.812 D12.776.930.127.124.812
|
| Concept/Terms |
CCAAT-Enhancer-Binding Protein-delta- CCAAT-Enhancer-Binding Protein-delta
- CCAAT Enhancer Binding Protein delta
- Nuclear Factor Interleukin 6beta
- Interleukin-6beta Nuclear Factor
- Interleukin 6beta Nuclear Factor
- C-EBP delta Protein
- C EBP delta Protein
- IL-6beta-NF
- IL 6beta NF
|
Below are MeSH descriptors whose meaning is more general than "CCAAT-Enhancer-Binding Protein-delta".
Below are MeSH descriptors whose meaning is more specific than "CCAAT-Enhancer-Binding Protein-delta".
This graph shows the total number of publications written about "CCAAT-Enhancer-Binding Protein-delta" by people in this website by year, and whether "CCAAT-Enhancer-Binding Protein-delta" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "CCAAT-Enhancer-Binding Protein-delta" by people in Profiles.
-
Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD. Cancer Cell. 2024 Aug 12; 42(8):1450-1466.e11.
-
Systematic transcriptome profiling of hPSC-derived osteoblasts unveils CORIN's mastery in governing osteogenesis through CEBPD modulation. J Biol Chem. 2024 Aug; 300(8):107494.
-
C/EBPd links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes. Oncogene. 2019 05; 38(20):3765-3780.
-
Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics. Sci Rep. 2017 11 22; 7(1):16068.
-
Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia. J Biol Chem. 2015 Apr 24; 290(17):11177-87.
-
Stat3 activation links a C/EBPd to myostatin pathway to stimulate loss of muscle mass. Cell Metab. 2013 Sep 03; 18(3):368-79.
-
Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPd) CpG island in breast cancer is associated with metastatic relapse. Br J Cancer. 2012 Aug 07; 107(4):732-8.
-
RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity. Brain Res. 2012 Jun 26; 1462:100-11.
-
Metabolic response of mice to a postnatal ablation of CCAAT/enhancer-binding protein alpha. J Biol Chem. 2005 Nov 18; 280(46):38689-99.
-
Mitochondrial biogenesis and thyroid status maturation in brown fat require CCAAT/enhancer-binding protein alpha. J Biol Chem. 2002 Jun 14; 277(24):21489-98.